BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Experts in dermatology, medical aesthetics, tissue engineering - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.rbcconsultants.com
X-WR-CALDESC:Events for Experts in dermatology, medical aesthetics, tissue engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261109T190000
DTEND;TZID=America/New_York:20261109T200000
DTSTAMP:20261023T153137Z
CREATED:20261023T153137Z
LAST-MODIFIED:20261023T153137Z
UID:1758-1794250800-1794254400@www.rbcconsultants.com
SUMMARY:The Next Generation in Skin Health: Advanced Conjugates for Superior Formulation Performance
DESCRIPTION:Speaker: Lesley Clark-Loeser\, MD\, FAAD Board-Certified Dermatologist Co-Founder\, Precision Skin & Body Institute® Davie\, Florida \nModerator: Roxane Chabot President RBC Consultants \nPlease join us for our next RBC Consultants Educational Series Webinar: The Next Generation in Skin Health: Advanced Conjugates for Superior Formulation Performance. Please join Dr. Clark-Loeser for a detailed overview on how skinbetter science has harnessed conjugate molecules to advance treatment outcomes. Learn how AlphaRet Overnight Cream and AMPRA Volumizing Macro HA Serum are creating paradigm shifts in expected outcomes from topical skincare. \n  \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/the-next-generation-in-skin-health-advanced-conjugates-for-superior-formulation-performance/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261110T190000
DTEND;TZID=America/New_York:20261110T200000
DTSTAMP:20261027T215837Z
CREATED:20261027T215837Z
LAST-MODIFIED:20261027T215837Z
UID:1760-1794337200-1794340800@www.rbcconsultants.com
SUMMARY:Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies
DESCRIPTION:Speakers: April W. Armstrong\, MD\, MPH\, FAAD and Eingun James Song\, MD\, FAAD \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies. This educational webinar will provide an overview of moderate-to-severe atopic dermatitis as a chronic\, relapsing inflammatory disease driven by underlying type 2 immune dysregulation and skin barrier dysfunction. April W. Armstrong\, MD\, MPH\, FAAD will review the clinical presentation\, disease burden\, and impact on patients’ quality of life\, including pruritus\, sleep disturbance\, and psychosocial effects. The session will also highlight current challenges in disease management and ongoing unmet needs\, offering insights to support a deeper understanding of atopic dermatitis and inform clinical decision-making. and EBGLYSS®(lebrikizumab-lbkz): What could less mean for your patients? Join your colleagues for a peer discussion exploring the latest EBGLYSS data. This program is sponsored by\, and the speaker is presenting on behalf of\, Lilly USA\, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit. Please see Prescribing Information and Patient Information at the product theater or on https://ebglyss.lilly.com. Please see Instructions for use included with the device. EBGLYSS® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company\, its subsidiaries\, or affiliates. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/advancing-care-in-moderate-to-severe-atopic-dermatitis-disease-insights-and-emerging-targeted-therapies-5/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261112T190000
DTEND;TZID=America/New_York:20261112T200000
DTSTAMP:20261103T125611Z
CREATED:20261103T125611Z
LAST-MODIFIED:20261103T125611Z
UID:1793-1794510000-1794513600@www.rbcconsultants.com
SUMMARY:Earlier Intervention with COSENTYX® (secukinumab) and Long-Term Impact
DESCRIPTION:Speaker: Graham Litchman\, DO\, MS\, FAAD Board-Certified Dermatologist and Clinical Researcher Clinical Assistant Professor\, University of Nevada\, Las Vegas Adjunct Clinical Faculty\, Touro University Nevada Program Director\, Dermatology Clinical Research Fellowship Co-Director of Clinical Trials\, Vivida Dermatology Associate Editor\, Journal of Clinical and Aesthetic Dermatology and Dermatology Online Journal Las Vegas\, Nevada \nModerator: Leon Kircik\, MD\, FAAD Medical Director\, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nPlease join us for our next IDF Educational Series Webinar: Earlier Intervention with COSENTYX® (secukinumab) and Long-Term Impact \nREGISTERHERE
URL:https://www.rbcconsultants.com/event/earlier-intervention-with-cosentyx-secukinumab-and-long-term-impact-3/
END:VEVENT
END:VCALENDAR